VisionWave Acquires QuantumSpeed(TM): A Pre-Commercial Computational Acceleration Engine Currently in Proof-of-Concept Phase Designed to Collapse Decision Latency

(NasdaqGM:VWAV),(NASDAQ:VWAVW), WEST HOLLYWOOD, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV) today announced the acquisition of QuantumSpeed(TM), an early-stage, pre-commercial computational acceleration engine that is intended to explore new approaches to execute complex computations under extreme time constraints. QuantumSpeed is not yet a commercial product. The technology is currently in a […]

HHM Hotels Adds Senior Operational Executive Chris Lorino

Philadelphia, PA, Jan. 07, 2026 (GLOBE NEWSWIRE) — HHM Hotels, a leader in hotel management and investment, announced the joining of Chris Lorino as its newest Executive Vice President of Operations. The hire fortifies HHM Hotels' position as an industry leader with its growing and stable portfolio with over 235 North American hotels. “We are

Thrive Honors 2026 Outstanding Partner Award Winners

BOSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) — Thrive, a global technology outsourcing provider for cybersecurity, cloud, and IT managed services, today announced the winners of its Outstanding Partner Awards. Thrive is pleased to recognize Avant Communications as Technology Solutions Distributor (TSD) of the Year, Data Technology Brokers as Partner of the Year, and Bridgepointe Technologies

GlobalFoundries Announces Conference Call to Review Fourth Quarter and Full-Year 2025 Financial Results

(NASDAQ:GFS), MALTA, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call on Wednesday, February 11, 2026, at 8:30 a.m. ET following the release of the company's fourth quarter and full-year 2025 financial results. Conference Call and Webcast Information The company will host a conference call

FibroBiologics CEO Issues Letter to Shareholders

FibroBiologics CEO Issues Letter to Shareholders GlobeNewswire January 07, 2026 HOUSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today issued the following

ASP Isotopes Closes Acquisition of Renergen

ASP Isotopes Closes Acquisition of Renergen GlobeNewswire January 07, 2026 Combined Company Expected to Become a Global Critical Materials Provider Focused on High-Growth Industries in Isotope and Helium Markets Renergen Expected to Benefit from $750 million of Committed Debt Funding from the U.S. government's Development Finance Corporation (U.S. DFC) and Other Lenders to Expand Helium

CRITICAL METALS CORP NASDAQ-CRML Officially Approves & Commences Construction Start-Up in Greenland for Tanbreez Pilot Plant & Multi-Use Facilities

CRITICAL METALS CORP NASDAQ-CRML Officially Approves & Commences Construction Start-Up in Greenland for Tanbreez Pilot Plant & Multi-Use Facilities GlobeNewswire January 07, 2026 Highlights Construction Approved in Greenland: CRML has formally approved the start of construction for an Arctic-grade, multi-use storage, housing and pilot-plant facilities in Qaqortoq under a full turnkey contract, supporting advancement of

Navitas to Present at the Needham Growth Conference on January 14, 2026

Navitas to Present at the Needham Growth Conference on January 14, 2026 GlobeNewswire January 07, 2026 TORRANCE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Navitas Semiconductor, an industry leader in next-generation GaNFast(TM) gallium nitride (GaN) and GeneSiC(TM) silicon carbide (SiC) power semiconductors, today announced the company will participate at the 28th Annual Needham Growth Conference

Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 THE WOODLANDS, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15 at 12:00 p.m. PT (3:00 p.m.

DeFi Development Corp. Releases 2025 Year in Review Highlighting Breakout Growth and Solana Treasury Leadership

DeFi Development Corp. Releases 2025 Year in Review Highlighting Breakout Growth and Solana Treasury Leadership GlobeNewswire January 07, 2026 BOCA RATON, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the release of

Scroll to Top